ImmunologybioRxiv
ChAdOx1 nCoV-19 (AZD1222) vaccine elicits monoclonal antibodies with potent cross-neutralizing activity against SARS-CoV-2 viral variants
J. Seow, C. Graham, S. R. Hallett…·K. J. Doores
This study isolates monoclonal antibodies from a vaccinated individual and shows they neutralize multiple SARS-CoV-2 variants effectively.
DOI 10.1016/j.celrep.2022.110757